Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Open Access
- 1 July 2010
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (7), 1365-1372
- https://doi.org/10.1038/mt.2010.54
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Targeting mesenchymal stem cells to activated endothelial cellsBiomaterials, 2009
- Clinical aspects of inflammatory bowel diseaseEuropean Journal of Immunology, 2009
- Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrityThe Journal of Pathology, 2009
- Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2009
- Immunomodulation by Mesenchymal Stem CellsDiabetes, 2008
- Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cellsArthritis & Rheumatism, 2008
- Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of DiabetesThe International Journal of Cell Cloning, 2007
- Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of miceNature Immunology, 2006
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005
- The Immunology of Mucosal Models of InflammationAnnual Review of Immunology, 2002